STALICLA’s In-licensing of SFX-01

Goodwin Procter advised STALICLA on the deal. STALICLA announced its worldwide in-licensing of SFX-01, a patented composition of synthetic sulforaphane and alpha-cyclodextrin, from Evgen Pharma in neurodevelopmental...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Groupe Gorgé’s Acquisition of iXblue

Goodwin Procter advised Groupe Gorgé on the deal. Hogan Lovells advised BNP Paribas, BRED Banque Populaire, Banque Populaire Rives de Paris, Crédit Agricole Corporate and Investment...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Flores’ Recapitalization

Foley & Lardner LLP advised Century Equity Partners on the deal. Century Equity Partners and its portfolio company Flores & Associates LLC (Flores), a leading provider...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here